CIBC Bancorp USA’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05M Buy
11,607
+5,024
+76% +$294K ﹤0.01% 1099
2026
Q2
$252K Buy
+6,583
New +$173K ﹤0.01% 1648
2025
Q3
$134K Buy
+11,434
New +$149K ﹤0.01% 1324

Other funds holding TXG

CIBC Bancorp USA's TXG Position: Q3 2026 in Review

CIBC Bancorp USA increased its 10x Genomics (TXG) stake by 76% in Q3 2026, buying an estimated $294K and bringing the position to 11,607 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

CIBC Bancorp USA first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • CIBC Bancorp USA held 11,607 shares of 10x Genomics worth $1.05M as of Q3 2026.
  • CIBC Bancorp USA bought 5,024 10x Genomics shares in Q3 2026, an estimated $294K.
  • 10x Genomics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1099 holding.
  • CIBC Bancorp USA first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
  • 482 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.